Latest MedImmune Stories
BANGALORE, India, June 23, 2011 /PRNewswire/ -- Jubilant Biosys Ltd., Bengaluru, based subsidiary of Jubilant Life Sciences Ltd., and AstraZeneca, today announced another successful delivery of an early stage milestone in the Pain therapeutic area. The collaboration, initiated two years ago in the Neuroscience therapeutic area, has now expanded to Cardiovascular and Metabolic diseases and focuses on the delivery of a steady stream of preclinical outcomes to AstraZeneca,...
NESS ZIONA, Israel, June 16, 2011 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (TASE: BNDX) [http://www.biondvax.com ] today announced positive results from its first Phase II clinical trial of the Multimeric-001 Universal Influenza Vaccine.
- All tested doses were found safe and well-tolerated - - A single dose of 5 Âµg met the 3 CHMP immunogenicity criteria - QUEBEC CITY, June 8, 2011 /PRNewswire/ - Medicago Inc.
124 current and former female employees will share in settlement involving equal pay PHILADELPHIA, June 6, 2011 /PRNewswire-USNewswire/ -- AstraZeneca, one of the largest pharmaceutical companies in the world, will pay $250,000 to 124 women who were subjected to pay discrimination while working at the corporation's Philadelphia Business Center in Wayne, Pa.
STAMFORD, Conn., June 6, 2011 /PRNewswire-USNewswire/ -- AmeriCares has awarded its annual Power of Partnership Award to AstraZeneca for its outstanding commitment to increasing access to health care for people in need both here at home and throughout the developing world.
ALDERLEY PARK and WELWYN GARDEN CITY, England, May 31, 2011 /PRNewswire/ -- AstraZeneca (NYSE: AZN) and Heptares Therapeutics today announced they have entered a four-year collaboration focused on the potential discovery and development of new medicines targeting G-protein coupled receptors (GPCRs). GPCRs are among the largest and most important family of proteins found in the human body, yet they become highly unstable when removed from their natural membrane-bound environments.
GAITHERSBURG, Md., May 13, 2011 /PRNewswire/ -- MedImmune announced today it will present eight abstracts at the American Thoracic Society (ATS) International Conference in Denver, CO, May 13-18, 2011.
SAN DIEGO, May 10, 2011 /PRNewswire/ -- Pfenex Inc., an industry leader in protein expression through the Pfenex Expression Technology(TM) platform, announced today a three year strategic collaboration with MedImmune LLC, the global biologics business of AstraZeneca.
ROCKVILLE, Md., May 9, 2011 /PRNewswire/ -- Novavax, Inc.
SOUTH SAN FRANCISCO, Calif., May 3, 2011 /PRNewswire/ -- Rigel Pharmaceuticals, Inc.
- A political dynamiter.